A Study to Evaluate Buprenorphine Transdermal Patch in Chinese Subjects With Moderate to Severe Chronic Cancer Pain

NCT03967327 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

194

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer Pain

Interventions

DRUG: Buprenorphine transdermal patches
DRUG: Morphine Sulfate Sustained-Release Tablet

Sponsor

Mundipharma (China) Pharmaceutical Co. Ltd